Cibc Private Wealth Group, LLC Ionis Pharmaceuticals Inc Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 2,425 shares of IONS stock, worth $85,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,425
Previous 2,125
14.12%
Holding current value
$85,990
Previous $101,000
3.96%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IONS
# of Institutions
404Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$534 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$502 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$366 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$310 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$279 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.03B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...